Articles published by Can-Fite BioPharma Ltd.
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite to Submit IND for the Treatment of Pancreatic Cancer Patients with Namodenoson
June 13, 2023
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite Announces $7.5 Million Concurrent Registered Direct Offering and Private Placement
January 11, 2023
Via Business Wire
Tickers
CANF
Can-Fite Updates: Namodenoson Increases Survival for the Most Severe Patients with Advanced Liver Cancer
December 28, 2022
Via Business Wire
Tickers
CANF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.